SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
---|---|---|---|---|---|---|---|---|---|
11-Mar-24 4:09 PM View: | Foster-Cheek Kaye I Director | Agios Pharmaceuticals, Inc. (AGIO) | 07-Mar-24 | Sale | 1,285 | $31.62 | $40,631.70 | (14%) 9.01K to 7.72K | |
07-Mar-24 6:49 PM View: | Foster-Cheek Kaye I Director | Agios Pharmaceuticals, Inc. (AGIO) | 06-Mar-24 | Sale | 4,415 | $31.99 | $141,236.00 | (33%) 13.42K to 9.01K | |
05-Mar-24 4:08 PM View: | Burns James William Chief Legal Officer | Agios Pharmaceuticals, Inc. (AGIO) | 05-Mar-24 | Planned Option Sale | 2,642 | $32.57 | $86,049.90 | (7%) 39.81K to 37.17K | |
07-Mar-24 6:49 PM View: | Foster-Cheek Kaye I Director | Agios Pharmaceuticals, Inc. (AGIO) | 05-Mar-24 | Sale | 300 | $32.21 | $9,663.00 | (2%) 13.72K to 13.42K | |
05-Mar-24 4:20 PM View: | Gheuens Sarah Chief Medical Officer | Agios Pharmaceuticals, Inc. (AGIO) | 05-Mar-24 | Planned Option Sale | 2,642 | $32.57 | $86,049.90 | (6%) 41.71K to 39.07K | |
05-Mar-24 4:10 PM View: | Goff Brian Chief Executive Officer Director | Agios Pharmaceuticals, Inc. (AGIO) | 05-Mar-24 | Planned Option Sale | 4,156 | $32.57 | $135,361.00 | (7%) 57.94K to 53.78K | |
05-Mar-24 4:15 PM View: | Washburn Theodore James Jr. Principal Accounting Officer | Agios Pharmaceuticals, Inc. (AGIO) | 05-Mar-24 | Planned Option Sale | 1,214 | $32.57 | $39,540.00 | (20%) 6.01K to 4.8K | |
05-Mar-24 4:18 PM View: | Jones Cecilia Chief Financial Officer | Agios Pharmaceuticals, Inc. (AGIO) | 05-Mar-24 | Planned Option Sale | 672 | $32.57 | $21,887.00 | (4%) 15.51K to 14.84K | |
07-Mar-24 6:47 PM View: | Washburn Theodore James Jr. Principal Accounting Officer | Agios Pharmaceuticals, Inc. (AGIO) | 05-Mar-24 | Sale | 1,913 | $31.75 | $60,737.80 | (40%) 4.8K to 2.89K | |
05-Mar-24 4:10 PM View: | Goff Brian Chief Executive Officer Director | Agios Pharmaceuticals, Inc. (AGIO) | 01-Mar-24 | Option Exercise | 8,500 | -- | -- | 17% 49.44K to 57.94K | |
05-Mar-24 4:15 PM View: | Washburn Theodore James Jr. Principal Accounting Officer | Agios Pharmaceuticals, Inc. (AGIO) | 01-Mar-24 | Option Exercise | 3,127 | -- | -- | 121% 2.59K to 5.72K | |
05-Mar-24 4:18 PM View: | Jones Cecilia Chief Financial Officer | Agios Pharmaceuticals, Inc. (AGIO) | 01-Mar-24 | Option Exercise | 2,000 | -- | -- | 15% 13.51K to 15.51K | |
05-Mar-24 4:08 PM View: | Burns James William Chief Legal Officer | Agios Pharmaceuticals, Inc. (AGIO) | 01-Mar-24 | Option Exercise | 7,834 | -- | -- | 26% 30.68K to 38.52K | |
05-Mar-24 4:20 PM View: | Gheuens Sarah Chief Medical Officer | Agios Pharmaceuticals, Inc. (AGIO) | 01-Mar-24 | Option Exercise | 7,834 | -- | -- | 24% 32.58K to 40.41K | |
29-Feb-24 4:05 PM View: | Schenkein David P Director | Agios Pharmaceuticals, Inc. (AGIO) | 27-Feb-24 | Option Exercise | 69,329 | $31.64 | $2,193,570.00 | 15% 472.71K to 542.04K | |
29-Feb-24 4:05 PM View: | Schenkein David P Director | Agios Pharmaceuticals, Inc. (AGIO) | 27-Feb-24 | Option Sale | 69,329 | $34.67 | $2,403,590.00 | (13%) 542.04K to 472.71K | |
27-Feb-24 4:04 PM View: | Schenkein David P Director | Agios Pharmaceuticals, Inc. (AGIO) | 26-Feb-24 | Option Exercise | 20,411 | $31.64 | $645,804.00 | 4% 472.71K to 493.12K | |
27-Feb-24 4:04 PM View: | Schenkein David P Director | Agios Pharmaceuticals, Inc. (AGIO) | 26-Feb-24 | Option Sale | 20,411 | $33.19 | $677,441.00 | (4%) 493.12K to 472.71K | |
27-Feb-24 4:04 PM View: | Schenkein David P Director | Agios Pharmaceuticals, Inc. (AGIO) | 23-Feb-24 | Option Exercise | 47,731 | $31.64 | $1,510,210.00 | 10% 472.71K to 520.44K | |
27-Feb-24 4:04 PM View: | Schenkein David P Director | Agios Pharmaceuticals, Inc. (AGIO) | 23-Feb-24 | Option Sale | 47,731 | $33.05 | $1,577,510.00 | (9%) 520.44K to 472.71K | |
22-Feb-24 5:43 PM View: | Washburn Theodore James Jr. Principal Accounting Officer | Agios Pharmaceuticals, Inc. (AGIO) | 20-Feb-24 | Sale | 504 | $26.63 | $13,421.50 | (16%) 3.25K to 2.74K | |
14-Feb-24 5:51 PM View: | Burns James William Chief Legal Officer | Agios Pharmaceuticals, Inc. (AGIO) | 14-Feb-24 | Planned Option Sale | 545 | $25.14 | $13,701.30 | (2%) 32.21K to 31.67K | |
14-Feb-24 5:50 PM View: | Washburn Theodore James Jr. Principal Accounting Officer | Agios Pharmaceuticals, Inc. (AGIO) | 14-Feb-24 | Planned Option Sale | 273 | $25.14 | $6,863.22 | (8%) 3.52K to 3.25K | |
14-Feb-24 5:53 PM View: | Gheuens Sarah Chief Medical Officer | Agios Pharmaceuticals, Inc. (AGIO) | 14-Feb-24 | Planned Option Sale | 642 | $25.14 | $16,139.90 | (2%) 34.07K to 33.43K | |
14-Feb-24 5:50 PM View: | Washburn Theodore James Jr. Principal Accounting Officer | Agios Pharmaceuticals, Inc. (AGIO) | 12-Feb-24 | Option Exercise | 777 | -- | -- | 28% 2.74K to 3.52K | |
14-Feb-24 5:51 PM View: | Burns James William Chief Legal Officer | Agios Pharmaceuticals, Inc. (AGIO) | 12-Feb-24 | Option Exercise | 1,833 | -- | -- | 6% 30.38K to 32.21K | |
14-Feb-24 5:53 PM View: | Gheuens Sarah Chief Medical Officer | Agios Pharmaceuticals, Inc. (AGIO) | 12-Feb-24 | Option Exercise | 2,162 | -- | -- | 7% 31.91K to 34.07K | |
24-Jan-24 4:23 PM View: | Jones Cecilia Chief Financial Officer | Agios Pharmaceuticals, Inc. (AGIO) | 24-Jan-24 | Planned Option Sale | 1,886 | $21.64 | $40,813.00 | (13%) 14.96K to 13.07K | |
24-Jan-24 4:24 PM View: | Gheuens Sarah Chief Medical Officer | Agios Pharmaceuticals, Inc. (AGIO) | 24-Jan-24 | Planned Option Sale | 1,708 | $21.64 | $36,961.10 | (5%) 33.62K to 31.91K | |
24-Jan-24 4:22 PM View: | Fouse Jacqualyn A Director | Agios Pharmaceuticals, Inc. (AGIO) | 24-Jan-24 | Planned Option Sale | 10,722 | $21.64 | $232,024.00 | (8%) 139.97K to 129.25K | |
24-Jan-24 4:20 PM View: | Goff Brian Chief Executive Officer Director | Agios Pharmaceuticals, Inc. (AGIO) | 24-Jan-24 | Planned Option Sale | 7,635 | $21.64 | $165,221.00 | (13%) 57.07K to 49.44K | |
24-Jan-24 4:19 PM View: | Milanova Tsveta Chief Commercial Officer | Agios Pharmaceuticals, Inc. (AGIO) | 24-Jan-24 | Planned Option Sale | 1,618 | $21.64 | $35,013.50 | (11%) 14.85K to 13.23K | |
24-Jan-24 4:25 PM View: | Burns James William Chief Legal Officer | Agios Pharmaceuticals, Inc. (AGIO) | 24-Jan-24 | Planned Option Sale | 1,708 | $21.64 | $36,961.10 | (5%) 32.09K to 30.38K | |
24-Jan-24 4:20 PM View: | Goff Brian Chief Executive Officer Director | Agios Pharmaceuticals, Inc. (AGIO) | 20-Jan-24 | Option Exercise | 17,018 | -- | -- | 42% 40.05K to 57.07K | |
24-Jan-24 4:19 PM View: | Milanova Tsveta Chief Commercial Officer | Agios Pharmaceuticals, Inc. (AGIO) | 20-Jan-24 | Option Exercise | 5,448 | -- | -- | 58% 9.4K to 14.85K | |
24-Jan-24 4:24 PM View: | Gheuens Sarah Chief Medical Officer | Agios Pharmaceuticals, Inc. (AGIO) | 20-Jan-24 | Option Exercise | 5,750 | -- | -- | 21% 27.87K to 33.62K | |
24-Jan-24 4:22 PM View: | Fouse Jacqualyn A Director | Agios Pharmaceuticals, Inc. (AGIO) | 20-Jan-24 | Option Exercise | 23,900 | -- | -- | 21% 116.08K to 139.97K | |
24-Jan-24 4:23 PM View: | Jones Cecilia Chief Financial Officer | Agios Pharmaceuticals, Inc. (AGIO) | 20-Jan-24 | Option Exercise | 5,380 | -- | -- | 56% 9.57K to 14.96K | |
24-Jan-24 4:25 PM View: | Burns James William Chief Legal Officer | Agios Pharmaceuticals, Inc. (AGIO) | 20-Jan-24 | Option Exercise | 5,750 | -- | -- | 22% 26.34K to 32.09K | |
09-Jan-24 4:26 PM View: | Fouse Jacqualyn A Director | Agios Pharmaceuticals, Inc. (AGIO) | 09-Jan-24 | Planned Option Sale | 8,391 | $22.99 | $192,909.00 | (7%) 124.47K to 116.08K | |
09-Jan-24 4:28 PM View: | Goff Brian Chief Executive Officer Director | Agios Pharmaceuticals, Inc. (AGIO) | 09-Jan-24 | Planned Option Sale | 12,066 | $22.99 | $277,397.00 | (23%) 52.12K to 40.05K | |
09-Jan-24 4:25 PM View: | Burns James William Chief Legal Officer | Agios Pharmaceuticals, Inc. (AGIO) | 09-Jan-24 | Planned Option Sale | 1,163 | $22.99 | $26,737.40 | (4%) 27.5K to 26.34K | |
09-Jan-24 4:22 PM View: | Gheuens Sarah Chief Medical Officer | Agios Pharmaceuticals, Inc. (AGIO) | 09-Jan-24 | Planned Option Sale | 1,789 | $22.99 | $41,129.10 | (6%) 29.66K to 27.87K | |
09-Jan-24 4:26 PM View: | Fouse Jacqualyn A Director | Agios Pharmaceuticals, Inc. (AGIO) | 05-Jan-24 | Option Exercise | 17,500 | -- | -- | 16% 106.97K to 124.47K | |
05-Jan-24 4:10 PM View: | Milanova Tsveta Chief Commercial Officer | Agios Pharmaceuticals, Inc. (AGIO) | 05-Jan-24 | Planned Option Sale | 2,902 | $22.32 | $64,772.60 | (24%) 12.31K to 9.4K | |
09-Jan-24 4:25 PM View: | Burns James William Chief Legal Officer | Agios Pharmaceuticals, Inc. (AGIO) | 05-Jan-24 | Option Exercise | 3,250 | -- | -- | 13% 24.25K to 27.5K | |
09-Jan-24 4:28 PM View: | Goff Brian Chief Executive Officer Director | Agios Pharmaceuticals, Inc. (AGIO) | 05-Jan-24 | Option Exercise | 25,527 | -- | -- | 96% 26.59K to 52.12K | |
09-Jan-24 4:22 PM View: | Gheuens Sarah Chief Medical Officer | Agios Pharmaceuticals, Inc. (AGIO) | 05-Jan-24 | Option Exercise | 5,000 | -- | -- | 20% 24.66K to 29.66K | |
05-Jan-24 4:10 PM View: | Milanova Tsveta Chief Commercial Officer | Agios Pharmaceuticals, Inc. (AGIO) | 03-Jan-24 | Option Exercise | 8,475 | -- | -- | 221% 3.83K to 12.31K | |
28-Sep-23 4:02 PM View: | Jones Cecilia Chief Financial Officer | Agios Pharmaceuticals, Inc. (AGIO) | 28-Sep-23 | Planned Option Sale | 2,179 | $24.79 | $54,017.40 | (19%) 11.75K to 9.57K |